| Mr Kurt Vanderveen, PA-C | |
|
3434 Rivertown Point Ct Sw, Grandville, MI 49418-3076 | |
| (616) 257-3344 | |
| (616) 257-1491 |
| Full Name | Mr Kurt Vanderveen |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 20 Years |
| Location | 3434 Rivertown Point Ct Sw, Grandville, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407941396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 5601004356 (Michigan) | Secondary |
| 363A00000X | Physician Assistant | 5601004356 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wolverine Dermatology Pc | 9638435191 | 5 |
News Archive
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
New research from University of North Carolina at Chapel Hill shows how a protein may be crucial to the regulation of genes in embryonic stem cells.
Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent.
Minority and multiracial children experience many disparities in medical and oral health status, access to care, and use of services, according to a new national study by researchers at the Center for Advancement of Underserved Children at the Medical College of Wisconsin in Milwaukee and Children's Hospital of Wisconsin.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kurt Vanderveen, PA-C 3434 Rivertown Point Ct Sw, Grandville, MI 49418-3076 Ph: (616) 257-3344 | Mr Kurt Vanderveen, PA-C 3434 Rivertown Point Ct Sw, Grandville, MI 49418-3076 Ph: (616) 257-3344 |
News Archive
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
New research from University of North Carolina at Chapel Hill shows how a protein may be crucial to the regulation of genes in embryonic stem cells.
Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent.
Minority and multiracial children experience many disparities in medical and oral health status, access to care, and use of services, according to a new national study by researchers at the Center for Advancement of Underserved Children at the Medical College of Wisconsin in Milwaukee and Children's Hospital of Wisconsin.
› Verified 6 days ago